The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobinson Regulatory News (RBN)

Share Price Information for Robinson (RBN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 100.00
Bid: 95.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 10.00 (10.526%)
Open: 100.00
High: 100.00
Low: 100.00
Prev. Close: 100.00
RBN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

18 Jan 2024 07:00

RNS Number : 0708A
Robinson PLC
18 January 2024
 

Robinson plc

18 January 2024

 

YEAR END TRADING STATEMENT

 

Robinson plc ("Robinson", the "Company" or the "Group" stock code: RBN), the custom manufacturer of plastic and paperboard packaging based in Chesterfield, is pleased to issue the following trading statement, prior to the announcement of its final results for the year ended 31 December 2023, which are scheduled to be released on 22 March 2024.

Revenue for 2023 is anticipated to be £49.6m, which is 1.8% below the prior year. After adjusting for price changes and foreign exchange, sales volumes are 6% lower than in 2022. However, the Company is pleased to report that 2023 operating profit before exceptional items and amortisation of intangible assets is expected to be ahead of 2022, and in line with current market expectations.

We anticipated that sales volumes would come under further pressure because of inflation, the cost-of-living crisis, the de-listing of some products by our customers, and certain of our customers continuing to prioritise existing business over innovation projects, a characteristic which started during the Covid-19 pandemic. These factors have manifested in lower sales in 2023, notably in the first half of the financial year. As previously announced, with the lower demand and continued inflationary pressures, we implemented a restructuring program in June, which resulted in exceptional costs of c.£0.4m and annual savings of c.£0.7m, of which £0.4m benefited 2023.

We believe we have now passed the worst of the downturn with our customers; sales volumes in the second half of 2023 were 1% above the comparative period in 2022, as implemented new projects began to take effect. As a result of successful sales activity, we expect a substantial increase in sales volume in the plastics business in 2024.

Net debt at 31 December 2023 is expected to be £6.3m (31/12/2022: £9.2m) including the receipt of £0.7m proceeds on sale of surplus property and the return of the defined benefit pension escrow funds of £3.3m in the period.

Impact of Storm Babet

The Company announced on 24 October 2023 that the River Hipper, which flows through our premises in Chesterfield, had risen to its highest ever recorded level and flooded part of the site. Part of the premises are occupied by the Group, including the Paperbox manufacturing business and the Group head office; the remainder is let to tenants. The Paperbox business represented 4.5% of the Group's revenues in 2023 (2022: 4.0%). The Group's plastics business was unaffected.

Despite the substantial efforts of our employees, some damage was caused to facilities, materials and equipment and manufacturing operations were paused. Our insurance covers facilities, materials, equipment and business interruption, with an excess of £100,000. The insurers' liability for the loss was confirmed in November and subsequently an interim payment of £450,000 was received by Robinson in December. The impact on the 2023 results is expected to be an exceptional cost of £0.1m.

The majority of the cleaning activities are now complete, but on-site manufacturing continues to be disrupted due to the scale of the clean-up operations and complications in re-instating damaged plant and machinery. Customer orders are being met through sub-contracting.

CEO position

As previously announced, Dr Helene Roberts resigned as CEO and a Director of the Company on 1 September 2023, at which point Sara Halton assumed responsibility as the Interim CEO. The selection process is underway, and the Directors expect to make an announcement on the appointment of a permanent CEO in due course.

Property

As previously announced, part of the Walton Works surplus property in Chesterfield, known as "Mill Lane", was sold on 30 May 2023. The consideration of £0.7m was received in cash and used to reduce bank debt.

On 11 August 2023, the Company also exchanged contracts for the sale of c.1.3 acres of the Walton Works surplus property. Completion is subject to conditions, notably including satisfactory planning approval, and is currently expected to take up to 18 months. The consideration payable on completion would be £1.5m in cash, with estimated Company costs of £0.4m. The net proceeds of £1.1m would be used by the Company to reduce current bank debt or invested in the listed Walton Mill buildings to enhance their saleability. Including this property transaction, which is not yet completed, the Directors estimate that the current market value of the remaining surplus properties held by the Group is approximately £7.4m.

We expect further sales of surplus property in Chesterfield to be achieved in the next 12 months. The intention of the Group is, over time, to realise value from the disposal of surplus properties and use the proceeds to reduce indebtedness and develop our packaging business.

Defined benefit pension scheme

In December 2022, the Robinson & Sons' Limited Pension Fund (the "Scheme") completed a buy-in of all the Group's defined benefit pension scheme liabilities with a plan to complete a full buy-out during 2023. A data cleanse exercise was completed, and the administration and payroll functions were handed over to Legal and General Assurance Society Limited from 1 August 2023. Whilst the final buy-out has been delayed slightly, full completion is now expected to take place very shortly. Any surplus remaining in the Scheme after the full buy-out would be used to augment member benefits. Non-cash exceptional costs are estimated to be approximately £0.3m in 2023, including the costs of enhancing the benefits of active members and the expenses of moving towards buyout. These costs are payable by the Scheme but accounted for in the Company under IAS19.

As announced on 14 August 2023, the Company reached agreement with the trustees of the Scheme for the funds held in the pension escrow account, totalling c.£3.3m, to be returned to the Group (of which, £2.7m was already loaned to the Company), and this was included in the reduced net debt at 31 December 2023. The Group will recognise an exceptional profit of c.£3.3m for this item in its income statement for 2023.

2024 Outlook

Following improved momentum in the second half of 2023 and reflecting the effect of new customer projects and the full year impact of cost savings, the Company expects revenue, and operating profit (before amortisation of intangible assets and any exceptional items), for the 2024 financial year to be ahead of 2023.

Robinson plc

www.robinsonpackaging.com

Sara Halton, Interim CEO

Mike Cusick, Finance Director

Tel: 01246 389280

Cavendish Capital Markets Limited

Ed Frisby / Seamus Fricker, Corporate Finance

Tim Redfern, Corporate Broking

Tel: 020 7220 0500

 

About Robinson:

 

Being a purpose-led business, Robinson specialises in custom packaging with technical and value-added solutions for food and consumer product hygiene, safety, protection, and convenience; going above and beyond to create a sustainable future for our people and our planet. Its main activity is in injection and blow moulded plastic packaging and rigid paperboard luxury packaging, operating within the food and beverage, homecare, personal care and beauty, and luxury gift sectors. Robinson provides products and services to major players in the fast-moving consumer goods market including Procter & Gamble, Reckitt Benckiser, SC Johnson and Unilever.

 

Headquartered in Chesterfield, UK, Robinson has plants in the UK, Poland and Denmark. Robinson was formerly a family business with its origins dating back to 1839, currently employing nearly 400 people. The Group also has a substantial property portfolio with development potential.

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFXFSELEFA
Date   Source Headline
19th Apr 20242:45 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSFinal Results
18th Jan 20247:00 amRNSTrading Statement
24th Oct 20232:35 pmRNSImpact of Storm Babet
17th Aug 20237:00 amRNSInterim Results
14th Aug 20237:00 amRNSCompany Update and Notice of Results
23rd Jun 20237:00 amRNSResult of AGM
22nd Jun 20237:00 amRNSAGM Statement
31st May 20237:00 amRNSSale of Property
30th Mar 20237:00 amRNSFinal Results
24th Jan 20237:00 amRNSTrading Statement
7th Dec 20221:15 pmRNSDefined Benefit Pension Scheme Buy In
8th Sep 20227:00 amRNSInterim Results
22nd Aug 202212:30 pmRNSDirector/PDMR Shareholding
26th May 20223:00 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement
28th Apr 20227:00 amRNSSale of Property
24th Mar 20227:00 amRNSFinal Results
9th Dec 20217:00 amRNSTrading Statement
28th Sep 20219:19 amRNSCapital Markets Day
24th Aug 20214:40 pmRNSSecond Price Monitoring Extn
24th Aug 20214:35 pmRNSPrice Monitoring Extension
19th Aug 20217:00 amRNSInterim Results
24th Jun 20211:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAGM Trading Statement
16th Jun 20211:15 pmRNSAGM - Change Of Format
15th Apr 202111:00 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSAcquisition Funding Update
11th Feb 20217:00 amRNSAcquisition
21st Jan 20217:00 amRNSTrading Statement
18th Aug 20207:00 amRNSInterim Results
17th Jul 202010:49 amRNSGrant of Options & PDMR Dealing
30th Jun 20201:30 pmRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
8th Jun 20209:11 amRNSNotice of AGM
17th Apr 20203:50 pmRNSDirector/PDMR Shareholding
1st Apr 20207:00 amRNSFinal Results
26th Mar 20206:28 pmRNSDelay in the publication of Financial Statements
12th Dec 20197:00 amRNSTrading Statement
29th Aug 201910:14 amRNSHolding(s) in Company
21st Aug 20197:00 amRNSInterim Results
20th Aug 20197:00 amRNSChief Executive Appointment
18th Jul 20194:00 pmRNSDirector/PDMR Shareholding
20th May 201910:41 amRNSHolding(s) in Company
9th May 20194:28 pmRNSResult of AGM
9th May 20197:00 amRNSAGM Statement
22nd Mar 20197:00 amRNSFinal Results
21st Jan 20197:00 amRNSTrading Statement
31st Dec 20187:00 amRNSDirector Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.